COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article Access statistics

Viewed: 498

Emailed: 0

PDF Downloaded: 185

IP International Journal of Medical Microbiology and Tropical Diseases


HBV co-infection in HIV infected patients and its effect on progress of the disease


Full Text PDF Share on Facebook Share on Twitter


Author Details : Bhagyashri R. Jadhav, Vidya P. Arjunwadkar, Renu S. Bharadwaj

Volume : 4, Issue : 1, Year : 2018

Article Page : 21-26


Suggest article by email

Abstract

Introduction: Co-infection of Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) is a common event due to similar routes of transmission, with significant clinical implications. Progression to liver disease is more rapid in HIV-HBV co-infected patients. The present study was designed to find the sero-prevalence of HBV in newly diagnosed HIV positive patients.
Materials and Methods: 200 newly diagnosed HIV positive cases were enrolled in present study. 3-5 cc blood was collected from these patients and HBsAg ELISA was carried out on serum obtained. HBsAg positive samples were processed further to detect HBeAg and anti-HBeAg by ELISA. Liver Function Tests (LFTs) and CD4 T cell count were noted.
Results: Out of 200 HIV positive patients, 4% were co-infected with HBV. Out of the 4% co-infected cases   37.5% were HBeAg positive and 62.5% were anti-HBe positive None of the HIV-HBV co-infected case had a CD4 T-cell count >500 cells/µL whereas 55.2% of  HIV mono-infected cases had CD4 T-cell counts > 500 cells/µL. 37.5% HIV-HBV co-infected cases had CD4 T-cell count ≤200 cells/µL whereas only 11.4% HIV mono-infected cases had CD4 T-cell count ≤200 cells/µL.HIV-HBV co-infected cases had more deranged liver enzymes. 50% of HIV-HBV co-infected cases belonged to WHO stage II, whereas majority (91.6%) of HIV mono-infected cases belonged to WHO stage I.
Conclusion: This study highlights that, routine screening of HBsAg should done in all HIV infected patients and virological markers of HBV, Liver Function Tests and CD4 T cell count of HIV-HBV co-infected patients should be assessed for appropriate management.

Keywords: HIV-HBV Co-infection-Correlation: CD4 Count, WHO staging, LFT.

Doi : 10.18231/2455-6807.2018.0005

How to cite : Jadhav B R, Arjunwadkar V P, Bharadwaj R S, HBV co-infection in HIV infected patients and its effect on progress of the disease. IP Int J Med Microbiol Trop Dis 2018;4(1):21-26

Copyright © 2018 by author(s) and IP Int J Med Microbiol Trop Dis. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)